Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences IncfiledCriticalPrometic Biosciences Inc
Priority to TNTNSN03022ApriorityCriticalpatent/TNSN03022A1/en
Publication of TNSN03022A1publicationCriticalpatent/TNSN03022A1/en
A method for treating, eliminating and preventing an inflammation of the skin or mucous membrane of a mammal, including a human, by administering to the skin or mucous membrane a composition containing dimethicone and a pharmaceutically acceptable carrier. The dimethicone composition is applied to the skin or mucous membrane in an amount effective to treat, eliminate or prevent the inflammation.
TNTNSN03022A2003-05-082003-05-08Method for treatment of inflammation
TNSN03022A1
(en)
Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence